TNDM

Tandem Diabetes Care, Inc.

19.11

USD

-0.68

-3.44%

Oct 30, 15:00 UTC -5

Closed

After-Market

18.97

-0.14

-0.73%

Tandem Diabetes Care, Inc. (TNDM) Earnings

TNDM Earnings Reports

Positive Surprise Ratio

TNDM beat 23 of 43 last estimates.

53%

Next Report

In 4 Days

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

$271.24M

-$0.24

Implied change from Q2 26 (Revenue/ EPS)

+6.55%

-22.58%

Implied change from Q3 25 (Revenue/ EPS)

+8.82%

-22.58%

Tandem Diabetes Care, Inc. earnings per share and revenue

On Aug 06, 2026, TNDM reported earnings of -0.31 USD per share (EPS) for Q2 26, beating the estimate of -0.32 USD, resulting in a 4.94% surprise. Revenue reached 254.56 million, compared to an expected 260.08 million, with a -2.12% difference. The market reacted with a +19.11% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of -0.24 USD, with revenue projected to reach 271.24 million USD, implying an decrease of -22.58% EPS, and increase of 6.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Alphatec Holdings, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.09

Actual

$0.09

Surprise

-6.83%

iRadimed Corporation

Report Date

Oct 30, 2026 For Q3 26

Estimate

$0.55

Actual

$0.55

Surprise

-1.66%

Beta Bionics, Inc. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.53

Actual

-$0.52

Surprise

+2.73%

Integra LifeSciences Holdings

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.57

Actual

$0.59

Surprise

+3.04%

OrthoPediatrics Corp. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.23

Surprise

-4.88%

ClearPoint Neuro, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.24

Surprise

+25.30%

Thermo Fisher Scientific, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$6.46

Actual

$6.68

Surprise

+3.29%

Intuitive Surgical Inc.

Report Date

Oct 20, 2026 For Q3 26

Estimate

$2.69

Actual

$3.00

Surprise

+11.29%

IQVIA Holdings Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$3.30

Actual

$3.34

Surprise

+0.97%

Glaukos Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.09

Actual

$0.47

Surprise

+611.98%

FAQ

What were Tandem Diabetes Care, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Tandem Diabetes Care, Inc. reported EPS of -$0.31, beating estimates by 4.94%, and revenue of $254.56M, -2.12% below expectations.

How did the market react to Tandem Diabetes Care, Inc.'s Q2 2026 earnings?

The stock price moved up 19.11%, changed from $18.79 before the earnings release to $22.38 the day after.

When is Tandem Diabetes Care, Inc. expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Tandem Diabetes Care, Inc.'s next earnings report?

Based on -- analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.24 and revenue of $271.24M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.